doi: 10.1111/1346-8138.12394
Journal of Dermatology 2014; 41: 2
EDITORIAL
Preface to Journal of Dermatology special issue: Lymphomas in Asia
From etiological and clinicopathological view points, various types of cutaneous lymphomas have been defined, and listed in the World Health Organization 2008 classification. Among them, adult T-cell leukemia/lymphoma (ATLL) and extranodal natural killer (NK)/T-cell lymphomas, nasal type (ENKL), are very unique because they both preferentially occur in Asia. Moreover, it is intriguing to note that patients with ATLL are often seen in Japan, but seldom encountered in Korea and eastern China, even though they are neighboring countries of Japan. The current special issue of the Journal of Dermatology constitutes two original articles, four review articles, three correspondences, and two meeting reports which highlight “Cutaneous lymphomas in Asia”. Drs Hamada et al. have reported results of a nationwide survey for cutaneous lymphomas in Japan between 2007 and 2011. Based on pathogenic studies, Drs Miyagaki and Sugaya have reviewed immunological milieu in mycosis fungoides/ zary syndrome. Drs Park and Ko have kindly contributed a Se review article on clinicopathological features of ENKL in Korea to the current issue. A consensus clinicopathological conference (CPC) on “Epstein–Barr virus-associated NK/T-cell lymphomas in the elderly” was held in Kofu in 2013, together with dermatologists and pathologists from Japan and Korea. The summary of the CPC has been published in the current issue as a meeting report.
2
Drs Tokura et al. have reviewed cutaneous manifestations of ATLL and the prognostic significance. A CPC on cutaneous ATLL was conducted in September 2013 by research groups supported by a grant from the Ministry of Health, Labour and Welfare, Japan. The consensus statements and discussion points among hematologists, pathologists and dermatologists have been published in the current issue as a meeting report (Drs Tsukasaki et al.). The first Japanese edition of guidelines for management of cutaneous lymphoma was published jointly in 2009 by the Japanese Dermatological Association (JDA) and the Japanese Skin Cancer Society (JSCS) – Lymphoma Study Group; the guidelines were revised in 2011, and published in English in 2013. Complementary to the JDA/JSCS guideline, we have added further information and our clinical experience of some currently available agents for cutaneous lymphomas in Japan. I would appreciate it if the current issue could be useful for better understanding of cutaneous lymphoma in Asia. Keiji IWATSUKI Department of Dermatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Okayama, Japan
© 2014 Japanese Dermatological Association
Journal of Dermatology 2014; 41: 2
EDITORIAL
Preface to Journal of Dermatology special issue: Lymphomas in Asia
From etiological and clinicopathological view points, various types of cutaneous lymphomas have been defined, and listed in the World Health Organization 2008 classification. Among them, adult T-cell leukemia/lymphoma (ATLL) and extranodal natural killer (NK)/T-cell lymphomas, nasal type (ENKL), are very unique because they both preferentially occur in Asia. Moreover, it is intriguing to note that patients with ATLL are often seen in Japan, but seldom encountered in Korea and eastern China, even though they are neighboring countries of Japan. The current special issue of the Journal of Dermatology constitutes two original articles, four review articles, three correspondences, and two meeting reports which highlight “Cutaneous lymphomas in Asia”. Drs Hamada et al. have reported results of a nationwide survey for cutaneous lymphomas in Japan between 2007 and 2011. Based on pathogenic studies, Drs Miyagaki and Sugaya have reviewed immunological milieu in mycosis fungoides/ zary syndrome. Drs Park and Ko have kindly contributed a Se review article on clinicopathological features of ENKL in Korea to the current issue. A consensus clinicopathological conference (CPC) on “Epstein–Barr virus-associated NK/T-cell lymphomas in the elderly” was held in Kofu in 2013, together with dermatologists and pathologists from Japan and Korea. The summary of the CPC has been published in the current issue as a meeting report.
2
Drs Tokura et al. have reviewed cutaneous manifestations of ATLL and the prognostic significance. A CPC on cutaneous ATLL was conducted in September 2013 by research groups supported by a grant from the Ministry of Health, Labour and Welfare, Japan. The consensus statements and discussion points among hematologists, pathologists and dermatologists have been published in the current issue as a meeting report (Drs Tsukasaki et al.). The first Japanese edition of guidelines for management of cutaneous lymphoma was published jointly in 2009 by the Japanese Dermatological Association (JDA) and the Japanese Skin Cancer Society (JSCS) – Lymphoma Study Group; the guidelines were revised in 2011, and published in English in 2013. Complementary to the JDA/JSCS guideline, we have added further information and our clinical experience of some currently available agents for cutaneous lymphomas in Japan. I would appreciate it if the current issue could be useful for better understanding of cutaneous lymphoma in Asia. Keiji IWATSUKI Department of Dermatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Okayama, Japan
© 2014 Japanese Dermatological Association
